Skip to main content.

Completed COVID/Post-COVID Trials

PB1046-PT-CL-0007 - VANGARD

A Randomized, Double-Blind, Parallel Group Study to Assess the Efficacy and Safety of Once Weekly Subcutaneous Injections of PB1046, a Sustained-Release VIP ANalogue, in Hospitalized COVID-19 patients at High Risk for Rapid Clinical Deterioration and ARDS (PB1046 VANGARD Study)

     More Information

Internal Medicine

University of Kansas Medical Center
Internal Medicine
Pulmonary, Critical Care, and Sleep Medicine Division
Mailstop 3007
3901 Rainbow Boulevard
Kansas City, KS 66160
Phone: 913-588-6045